{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:55:46Z","timestamp":1759010146548,"version":"3.37.3"},"reference-count":26,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T00:00:00Z","timestamp":1431302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004431","name":"Directorate-General for Research and Innovation","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Council, Copenhagen University Hospital, Rigshospitalet"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2015,10]]},"abstract":"Objectives<\/jats:title>The aim of the study was to investigate the organization and delivery of HIV<\/jats:styled-content> and tuberculosis (TB<\/jats:styled-content>) health care and to analyse potential differences between treatment centres in Eastern (EE<\/jats:styled-content>) and Western Europe (WE<\/jats:styled-content>).<\/jats:p><\/jats:sec>Methods<\/jats:title>Thirty\u2010eight E<\/jats:styled-content>uropean HIV<\/jats:styled-content> and TB<\/jats:styled-content> treatment centres participating in the TB<\/jats:styled-content>:HIV<\/jats:styled-content> study within EuroCoord<\/jats:styled-content> completed a survey on health care management for coinfected patients in 2013 (EE<\/jats:styled-content>: 17 respondents; WE<\/jats:styled-content>:21; 76% of all TB<\/jats:styled-content>:HIV<\/jats:styled-content> centres). Descriptive statistics were obtained for regional comparisons. The reported data on health care strategies were compared with actual clinical practice at patient level via data derived from the TB<\/jats:styled-content>:HIV<\/jats:styled-content> study.<\/jats:p><\/jats:sec>Results<\/jats:title>Respondent centres in EE<\/jats:styled-content> comprised: B<\/jats:styled-content>elarus (n<\/jats:italic>\u2009=\u20093), E<\/jats:styled-content>stonia (1), G<\/jats:styled-content>eorgia (1), L<\/jats:styled-content>atvia (1), L<\/jats:styled-content>ithuania (1), P<\/jats:styled-content>oland (4), R<\/jats:styled-content>omania (1), the R<\/jats:styled-content>ussian F<\/jats:styled-content>ederation (4) and U<\/jats:styled-content>kraine (1); those in WE<\/jats:styled-content> comprised: B<\/jats:styled-content>elgium (1), D<\/jats:styled-content>enmark (1), F<\/jats:styled-content>rance (1), I<\/jats:styled-content>taly (7), S<\/jats:styled-content>pain (2), S<\/jats:styled-content>witzerland (1) and UK<\/jats:styled-content> (8). Compared with WE, treatment of HIV and TB in EE<\/jats:styled-content> are less often located at the same site (47% in EE<\/jats:styled-content> versus 100% in WE; P<\/jats:italic>\u2009<\u20090.001) and less often provided by the same doctors (41% versus 90%, respectively; P<\/jats:italic>\u2009=\u20090.002), whereas regular screening of HIV<\/jats:styled-content>\u2010infected patients for TB<\/jats:styled-content> (80% versus 40%, respectively; P<\/jats:italic>\u2009=\u20090.037) and directly observed treatment (88% versus 20%, respectively; P<\/jats:italic>\u2009<\u20090.001) were more common in EE<\/jats:styled-content>. The reported availability of rifabutin and second\u2010 and third\u2010line anti\u2010TB<\/jats:styled-content> drugs was lower, and opioid substitution therapy (OST<\/jats:styled-content>) was available at fewer centres in EE<\/jats:styled-content> compared with WE<\/jats:styled-content> (53% versus 100%, respectively; P<\/jats:italic>\u2009<\u20090.001).<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Major differences exist between EE<\/jats:styled-content> and WE<\/jats:styled-content> in relation to the organization and delivery of health care for HIV<\/jats:styled-content>\/TB<\/jats:styled-content>\u2010coinfected patients and the availability of anti\u2010TB<\/jats:styled-content> drugs and OST<\/jats:styled-content>. Significant discrepancies between reported and actual clinical practices were found in EE<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12256","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T08:58:13Z","timestamp":1431334693000},"page":"544-552","source":"Crossref","is-referenced-by-count":18,"title":["Major differences in organization and availability of health care and medicines for HIV\/TB<\/scp> coinfected patients across E<\/scp>urope"],"prefix":"10.1111","volume":"16","author":[{"given":"M","family":"Mansfeld","sequence":"first","affiliation":[{"name":"CHIP (Centre for Health and Infectious Disease Research) Department of Infectious Diseases, Section 2100, Rigshospitalet \u2013 University of Copenhagen Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Skrahina","sequence":"additional","affiliation":[{"name":"Research Institute of Pulmonology and Pulmonary Tuberculosis Minsk Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Department of Infection and Population Health University College London Medical School London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schultze","sequence":"additional","affiliation":[{"name":"Department of Infection and Population Health University College London Medical School London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AM","family":"Panteleev","sequence":"additional","affiliation":[{"name":"TB Hospital #2 St Petersburg Russia"},{"name":"St Petersburg AIDS Centre St Petersburg Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RF","family":"Miller","sequence":"additional","affiliation":[{"name":"Centre for Sexual Health & HIV Research, Mortimer Market Centre University College London London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JM","family":"Miro","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Clinic University of Barcelona Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Zeltina","sequence":"additional","affiliation":[{"name":"Infectology Centre of Latvia Riga Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tetradov","sequence":"additional","affiliation":[{"name":"\u2018Dr Victor Babes\u2019 Hospital of Tropical and Infectious Diseases Bucharest Romania"},{"name":"\u2018Carol Davila\u2019 University of Medicine and Pharmacy Bucharest Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Furrer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Bern University Hospital and University of Bern Bern Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Kirk","sequence":"additional","affiliation":[{"name":"CHIP (Centre for Health and Infectious Disease Research) Department of Infectious Diseases, Section 2100, Rigshospitalet \u2013 University of Copenhagen Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Grzeszczuk","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology Medical University of Bialystok Bialystok Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Bolokadze","sequence":"additional","affiliation":[{"name":"Infectious Diseases AIDS and Clinical Immunology Research Center Tbilisi Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Matteelli","sequence":"additional","affiliation":[{"name":"Institute of Infectious and Tropical Diseases University of Brescia Brescia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FA","family":"Post","sequence":"additional","affiliation":[{"name":"King's College Hospital NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JD","family":"Lundgren","sequence":"additional","affiliation":[{"name":"CHIP (Centre for Health and Infectious Disease Research) Department of Infectious Diseases, Section 2100, Rigshospitalet \u2013 University of Copenhagen Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mocroft","sequence":"additional","affiliation":[{"name":"Department of Infection and Population Health University College London Medical School London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AMW","family":"Efsen","sequence":"additional","affiliation":[{"name":"CHIP (Centre for Health and Infectious Disease Research) Department of Infectious Diseases, Section 2100, Rigshospitalet \u2013 University of Copenhagen Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DN","family":"Podlekareva","sequence":"additional","affiliation":[{"name":"CHIP (Centre for Health and Infectious Disease Research) Department of Infectious Diseases, Section 2100, Rigshospitalet \u2013 University of Copenhagen Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"TB:HIV study group in EuroCoord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"volume-title":"UNAIDS Report on the Global AIDS Epidemic","year":"2013","author":"UNAIDS","key":"e_1_2_9_2_1"},{"volume-title":"Global Tuberculosis Report","year":"2014","author":"World Health Organization","key":"e_1_2_9_3_1"},{"key":"e_1_2_9_4_1","first-page":"2485","article-title":"HIV\/TB Study Writing Group. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina","volume":"18","author":"Podlekareva DN","year":"2009","journal-title":"AIDS"},{"doi-asserted-by":"publisher","key":"e_1_2_9_5_1","DOI":"10.1007\/s11904-014-0202-3"},{"doi-asserted-by":"publisher","key":"e_1_2_9_6_1","DOI":"10.1007\/s00586-012-2339-3"},{"key":"e_1_2_9_7_1","first-page":"874083","article-title":"TB and HIV therapeutics: pharzmacology research priorities","volume":"2012","author":"Dooley KE","year":"2012","journal-title":"AIDS Res Treat"},{"doi-asserted-by":"publisher","key":"e_1_2_9_8_1","DOI":"10.2471\/BLT.12.104588"},{"volume-title":"Multidrug and Extensively Drug\u2010Resistant TB (M\/XDR\u2010TB): 2010 Global Report on Surveillance and Response","year":"2010","author":"World Health Organization","key":"e_1_2_9_9_1"},{"volume-title":"The global plan to stop tuberculosis 2006\u20132015. Stop TB partnership","year":"2006","author":"World Health Organization","key":"e_1_2_9_10_1"},{"doi-asserted-by":"publisher","key":"e_1_2_9_11_1","DOI":"10.2471\/BLT.04.018705"},{"doi-asserted-by":"publisher","key":"e_1_2_9_12_1","DOI":"10.1093\/heapol\/czl014"},{"doi-asserted-by":"publisher","key":"e_1_2_9_13_1","DOI":"10.1111\/j.1468-1293.2008.00567.x"},{"doi-asserted-by":"publisher","key":"e_1_2_9_14_1","DOI":"10.5588\/ijtld.12.0224"},{"doi-asserted-by":"publisher","key":"e_1_2_9_15_1","DOI":"10.1196\/annals.1425.009"},{"key":"e_1_2_9_16_1","first-page":"1097","article-title":"Tuberculosis in Russia","volume":"4","author":"Perelman MI","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"unstructured":"World\u2002Health Organization. WHO Policy on Collaborative TB\/HIV Activities: Guidelines for National Programmes and Other Stakeholders.Geneva:World Health Organization 2012. Available athttp:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503006_eng.pdf(accessed 12 January 2014).","key":"e_1_2_9_17_1"},{"doi-asserted-by":"publisher","key":"e_1_2_9_18_1","DOI":"10.1371\/journal.pone.0046988"},{"doi-asserted-by":"publisher","key":"e_1_2_9_19_1","DOI":"10.1016\/j.drugpo.2007.03.001"},{"doi-asserted-by":"publisher","key":"e_1_2_9_20_1","DOI":"10.1056\/NEJMoa1013607"},{"doi-asserted-by":"publisher","key":"e_1_2_9_21_1","DOI":"10.1056\/NEJMoa1013911"},{"doi-asserted-by":"publisher","key":"e_1_2_9_22_1","DOI":"10.1016\/j.drugpo.2006.12.014"},{"doi-asserted-by":"publisher","key":"e_1_2_9_23_1","DOI":"10.1016\/j.drugalcdep.2012.11.013"},{"doi-asserted-by":"publisher","key":"e_1_2_9_24_1","DOI":"10.1183\/09031936.98.12040967"},{"doi-asserted-by":"publisher","key":"e_1_2_9_25_1","DOI":"10.1111\/hiv.12022"},{"doi-asserted-by":"publisher","key":"e_1_2_9_26_1","DOI":"10.1038\/506295c"},{"doi-asserted-by":"publisher","key":"e_1_2_9_27_1","DOI":"10.1016\/S0140-6736(10)60483-7"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12256","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:12:20Z","timestamp":1695478340000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1111\/hiv.12256"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12256","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2015,5,11]]}}}